课题基金 / 基金详情

Development of new periodontal treatment based on the suppression of ostaoclast differentiation factor (ODE) on T cells and osteoblasts

Development of new periodontal treatment based on the suppression of ostaoclast differentiation factor (ODE) on T cells and osteoblasts
基于抑制破骨细胞分化因子(ODE)对 T 细胞和成骨细胞的新型牙周治疗的开发
批准号:
14571977
负责人:
NAGASAWA Toshiyuki
金额:
$1.92万
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
2002
资助国家:
日本
项目状态:
已结题
起止时间:
2002 至 2003

项目摘要

项目成果

NAGASAWA Toshiyuki的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
The purpose of the present study was to investigate the expression of osteoclast differentiation factor (ODE) and osteopmtegerin (OPG) in periodontitis, and develop a novel treatment to suppress the ODF in periodontitis. The results of the study were as follows;1) Human gingival fibroblasts express OPG, but they don't express ODE suggesting that human gingival fibroblasts suppress osteoclastogenesis.2) Human periodontal ligament cells expressed ODF in response to inflammatory stimulation, suggesting that inflammation extending to periodontal ligament might augment alveolar bone resorption.3) Human periodontal ligament cells produce bone morphogenetic protein (BMP) -2 in response to transforming growth factor beta(TGF-b).These results suggests that adequate amount of human gingival fibroblasts are needed to suppress osteoclastogenesis in periodontitis, arid it is important to evade the inflammation in near the periodontal ligament cells.
期刊论文(28)
专著(0)
科研奖励(0)
会议论文
Mahanonda R, Sa-Ard-Jan N, Yongvanitchit K, Wisetchang M, Ishikawa I, Nagasawa T, Waish DS, Pichyangkul S: "Up-regulation of co-stimulatory molecule expression and dendritic cell marker (CD83) on B cells in periodontal disease"J Periodont Res. 37. 177-183
Mahanonda R、Sa-Ard-Jan N、Yongvanitchit K、Wisetchang M、Ishikawa I、Nagasawa T、Waish DS、Pichyangkul S:“牙周 B 细胞上共刺激分子表达和树突状细胞标记物 (CD83) 的上调
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Nagasawa T, Kobayashi H, Kiji M, Aramaki M, Mahanonda R, Kojima T, Murakarni Y, Saito M, Morotome Y, Ishikawa I: "LPS-stimulated human gingival fibroblasts inhibit the differentiation of monocytes into osteoclasts through the production of osteoprotegerin
Nagasawa T、Kobayashi H、Kiji M、Aramaki M、Mahanonda R、Kojima T、Murakarni Y、Saito M、Morotome Y、Ishikawa I:“LPS 刺激的人牙龈成纤维细胞通过产生骨保护素抑制单核细胞向破骨细胞的分化
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Kobayashi H, Nagasawa T, Aramaki M, Noguchi K, Oda S, Ishikawa I: "Effect of genotype and expression intensity of Fc-gamma-receptor IIIb (CD16) on the severity of periodontitis in Japanese population"Dentistry in Japan. 40. 120-123 (2004)
Kobayashi H、Nagasawa T、Aramaki M、Noguchi K、Oda S、Ishikawa I:“Fc-γ-受体 IIIb (CD16) 基因型和表达强度对日本人群牙周炎严重程度的影响”日本牙科。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Iwasaki K, Noguchi KJshikawa I.: "Prostaglandin E2 downregulates interleukm-12 production through EP4 receptors in human monocytes stimulated with lipopolysaccharide fiom Actinobacillus"Oral Microbiol Immunol. 18. 150-155 (2003)
Iwasaki K、Noguchi KJshikawa I.:“前列腺素 E2 通过放线杆菌脂多糖刺激的人单核细胞中的 EP4 受体下调白细胞介素 12 的产生”口腔微生物免疫学。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
13
    Diagnostic and regenerative strategies for periodontal tissue based on the Positional HOX signature
    • 批准号:
      20K09944
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $2.83万
    • 财政年份:
      2020
    • 负责人:
      NAGASAWA Toshiyuki
    • 依托单位:
    Hypertention caused by the agonistic autoantibodies associated with periodontitis
    • 批准号:
      17K11991
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $3.0万
    • 财政年份:
      2017
    • 负责人:
      NAGASAWA Toshiyuki
    • 依托单位:
    Examination of the effects of periodontitis on aging, and development of novel periodontal treatments
    • 批准号:
      23593069
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $3.33万
    • 财政年份:
      2011
    • 负责人:
      NAGASAWA Toshiyuki
    • 依托单位:
    Development of novel therapeutic approach for the prevention of alveolar bone destruction and atherosclerosis through the regulation of Wnt signaling
    • 批准号:
      20592425
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $2.91万
    • 财政年份:
      2008
    • 负责人:
      NAGASAWA Toshiyuki
    • 依托单位:
    国内基金
    海外基金
    基于RANKL/RANK/OPG通路观察补肾活血方干预半月板白-白区撕裂后软骨下骨的研究
    单核巨噬细胞通过RANK/RANKL/OPG 信号通路调控小鼠P3趾尖骨关节再生的机制研究
    • 批准号:
      JCZRYB202500176
    • 项目类别:
      省市级项目
    • 资助金额:
      --
    • 批准年份:
      2025
    • 负责人:
    • 依托单位:
    基于网络药理学技术及OPG/RANKL/RNAK信号通路探讨壮骨方防治假体无菌性松动机制研究
    OPG-RANKL-RANK轴调控NLRP3炎症小体介导DA神经元变性的分子机制研究
    • 批准号:
    • 项目类别:
      省市级项目
    • 资助金额:
      15.0万元
    • 批准年份:
      2024
    • 负责人:
      陈祥
    • 依托单位: